Insight Molecular Diagnostics Community

Key Takeaways Expanding clinical adoption and demographic trends are set to boost recurring revenue and gross margins through increased testing volume and broader market penetration. Strategic focus on high-margin digital PCR kits and new partnerships diversifies income sources, enhances profitability, and lessens dependence on external financing.